NCM
GILD icon

Narwhal Capital Management’s Gilead Sciences GILD Stock Holding History

Narwhal Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,625
Closed -$279K – 149
2020
Q2 		$279K Sell
3,625
-4,035
-53% -$309K 0.05% 120
2020
Q1 		$573K Buy
7,660
+3,625
+90% +$250K 0.12% 89
2019
Q4 		$262K Hold
4,035
– – 0.05% 123
2019
Q3 		$256K Sell
4,035
-23,900
-86% -$1.56M 0.05% 123
2019
Q2 		$1.89M Sell
27,935
-12,625
-31% -$831K 0.39% 66
2019
Q1 		$2.64M Sell
40,560
-1,615
-4% -$107K 0.57% 58
2018
Q4 		$2.64M Buy
42,175
+3,930
+10% +$275K 0.65% 55
2018
Q3 		$2.95M Buy
38,245
+4,695
+14% +$355K 0.65% 53
2018
Q2 		$2.38M Sell
33,550
-1,350
-4% -$95.3K 0.55% 62
2018
Q1 		$2.63M Sell
34,900
-7,410
-18% -$589K 0.61% 60
2017
Q4 		$3.03M Buy
42,310
+2,980
+8% +$226K 0.7% 50
2017
Q3 		$3.19M Buy
39,330
+2,825
+8% +$216K 0.79% 43
2017
Q2 		$2.58M Buy
36,505
+5,850
+19% +$389K 0.67% 52
2017
Q1 		$2.08M Buy
30,655
+4,465
+17% +$314K 0.58% 57
2016
Q4 		$1.88M Sell
26,190
-2,410
-8% -$179K 0.56% 58
2016
Q3 		$2.26M Buy
28,600
+1,780
+7% +$145K 0.71% 46
2016
Q2 		$2.24M Buy
26,820
+2,855
+12% +$253K 0.7% 49
2016
Q1 		$2.2M Buy
23,965
+4,375
+22% +$395K 0.72% 47
2015
Q4 		$1.98M Buy
19,590
+4,570
+30% +$476K 0.69% 53
2015
Q3 		$1.48M Buy
15,020
+2,310
+18% +$257K 0.55% 59
2015
Q2 		$1.49M Buy
12,710
+60
+0.5% +$6.56K 0.54% 65
2015
Q1 		$1.24M Buy
12,650
+150
+1% +$15.2K 0.45% 72
2014
Q4 		$1.18M Buy
12,500
+3,100
+33% +$321K 0.46% 75
2014
Q3 		$1M Hold
9,400
– – 0.4% 80
2014
Q2 		$779K Buy
+9,400
New +$732K 0.3% 102

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Narwhal Capital Management's GILD Position: Q3 2020 in Review

Narwhal Capital Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,625 shares — an estimated $279K sold.

Narwhal Capital Management first reported a position in GILD in Q2 2014 and held it in 25 quarters. The position peaked at $3.19M in Q3 2017. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Narwhal Capital Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Narwhal Capital Management sold 3,625 Gilead Sciences shares in Q3 2020, an estimated $279K.
  • Narwhal Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 25 quarters.
  • Narwhal Capital Management's Gilead Sciences position peaked at $3.19M in Q3 2017.
  • 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Narwhal Capital Management's 13F filing for Q3 2020, filed 26 Oct 2020.